Anti-SCIN monoclonal antibody

Pre-made anti-SCIN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SCIN/SCIN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2730-Ab-1/ GM-Tg-hg-IP2730-Ab-2Anti-Human SCIN monoclonal antibodyHuman
GM-Tg-rg-IP2730-Ab-1/ GM-Tg-rg-IP2730-Ab-2Anti-Rat SCIN monoclonal antibodyRat
GM-Tg-mg-IP2730-Ab-1/ GM-Tg-mg-IP2730-Ab-2Anti-Mouse SCIN monoclonal antibodyMouse
GM-Tg-cynog-IP2730-Ab-1/ GM-Tg-cynog-IP2730-Ab-2Anti-Cynomolgus/ Rhesus macaque SCIN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2730-Ab-1/ GM-Tg-felg-IP2730-Ab-2Anti-Feline SCIN monoclonal antibodyFeline
GM-Tg-cang-IP2730-Ab-1/ GM-Tg-cang-IP2730-Ab-2Anti-Canine SCIN monoclonal antibodyCanine
GM-Tg-bovg-IP2730-Ab-1/ GM-Tg-bovg-IP2730-Ab-2Anti-Bovine SCIN monoclonal antibodyBovine
GM-Tg-equg-IP2730-Ab-1/ GM-Tg-equg-IP2730-Ab-2Anti-Equine SCIN monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2730-Ab-1/ GM-Tg-hg-IP2730-Ab-2; GM-Tg-rg-IP2730-Ab-1/ GM-Tg-rg-IP2730-Ab-2;
GM-Tg-mg-IP2730-Ab-1/ GM-Tg-mg-IP2730-Ab-2; GM-Tg-cynog-IP2730-Ab-1/ GM-Tg-cynog-IP2730-Ab-2;
GM-Tg-felg-IP2730-Ab-1/ GM-Tg-felg-IP2730-Ab-2; GM-Tg-cang-IP2730-Ab-1/ GM-Tg-cang-IP2730-Ab-2;
GM-Tg-bovg-IP2730-Ab-1/ GM-Tg-bovg-IP2730-Ab-2; GM-Tg-equg-IP2730-Ab-1/ GM-Tg-equg-IP2730-Ab-2
Products NameAnti-SCIN monoclonal antibody
Formatmab
Target NameSCIN
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SCIN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2730-Ag-1Recombinant multi-species SCIN protein


    Target information

    Target IDGM-IP2730
    Target NameSCIN
    Gene ID85477,20259,298975,693551,475245,101101205,281478,100052612
    Gene Symbol and Synonymsadseverin,SCIN,Scind
    Uniprot AccessionQ9Y6U3,Q28046
    Uniprot Entry NameSCIN_HUMAN,SCIN_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000006747
    Target ClassificationN/A

    The target: SCIN, gene name: SCIN, also named as . SCIN is a Ca(2+)-dependent actin-severing and -capping protein (Zunino et al., 2001 [PubMed 11568009]).[supplied by OMIM, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.